Gan & Lee Pharmaceuticals Co., Ltd. Brand Ranking
Industry: drug , Insulin pen
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Gan & Lee Pharmaceuticals Co., Ltd.

Gan & Lee Pharmaceuticals Co., Ltd.

Gan & Lee Pharmaceuticals Co., Ltd.
Industry: drug , Insulin pen
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Brand Introduction

Ganli Pharmaceutical Co., Ltd. (stock abbreviation: Ganli Pharmaceutical, stock code: 603087.SH) was established in 1998. It is a high-tech biopharmaceutical company integrating scientific research, development, production and sales. It has 4 employees worldwide. More than 600 people. Headquartered in the southern district of Tongzhou Economic Development Zone, Beijing, it is affiliated to the Zhongguancun National Independent Innovation Demonstration Zone. The company has an industrial park of about 200,000 square meters.

As a company that was first in China to master the technology of industrial production of recombinant insulin analogs, Ganli Pharmaceutical is in the leading position in the Chinese diabetes market in the research and development of synthetic human insulin and its analogs, and has established close contact with well-known companies such as Sandoz. Cooperate and actively explore overseas markets. As a global company focusing on human health, Ganli Pharmaceutical adheres to a scientific and ultimate corporate culture and is committed to providing high-quality products and services to diabetic patients around the world.

Recommend Related Products

版权所有 © 宁波全贸信息技术有限公司 浙ICP备12012821号-1 浙B2-20200628

浙公网安备 33020902000078号